Christopher Miskovsky, MD
Hand Surgery · Dallas, TXNPI 1093710816
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (59.1%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Arthrex accounts for 62.1% of it on its own, with 22 other manufacturers making up the rest. 2025 is the largest year on record at $17,727, more than ten times the $616 reported in 2019.
Across 120 payments — averaging $261.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$20K
- Medartis Inc.$6K
- Pylant Medical$4K
- Johnson & Johnson$157
- Amgen$146
- Kerecis Limited$144
- plus $737 from 17 others
What the payments were for
- Consulting fees$18,57559%
- Speaking & faculty fees$750%
- Travel & lodging$5,39517%
- Food & beverage$4,21913%
- Education$3,15410%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 43 | $19,503 |
| Medartis Inc. | 6 | $6,243 |
| Pylant Medical | 26 | $4,490 |
| Johnson & Johnson | 8 | $157 |
| Amgen | 1 | $146 |
| Kerecis Limited | 1 | $144 |
| Integra Lifesciences Corporation | 7 | $142 |
| Ferring Pharmaceuticals Inc. | 6 | $114 |
| Vertex | 4 | $87 |
| Sanofi-aventis U.S. LLC | 4 | $84 |
| Trimed, Inc. | 1 | $48 |
| Acumed LLC | 1 | $33 |
| Kowa Pharmaceuticals America, Inc. | 2 | $30 |
| Axogen | 1 | $25 |
| Stryker | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $23 |
| Biocircuit Technologies Inc | 1 | $22 |
| Cumberland Pharmaceuticals, Inc. | 1 | $20 |
| Sonex Health, Inc. | 1 | $19 |
| Avanos Medical | 1 | $19 |
| Pacira Therapeutics, Inc. | 1 | $18 |
| Bioventus LLC | 1 | $16 |
| Abbott | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- APTUS$6,243
- Kerecis SurgiClose$575
- EVENITY$146
- Kerecis GraftGuide$144
- OTHER OTHER OTHER OTHER$125
How this compares
$31,419 in reported general payments places this provider in the 85th percentile of 170 hand surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tramadol Hcl | 72 | $222 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $119 |
| Methylprednisolone | 21 | $78 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 16 | $68 |
| Ondansetron OdtOndansetron | 13 | $56 |
Paid to pharmacies, not to this prescriber.
Other hand surgery in Dallas
- Daniel KoehlerDallas$208K
- Ann GoldenDallas$107K
- Kimberly MezeraDallas$39K
- David RingAustin$536K
- Kourosh JafarniaHouston$278K
- Brendan MackayLubbock$274K
- John FaillaceWoodway$212K
- Timothy NiacarisArlington$160K
- Steven NiedermeierArlington$152K
- William PientkaFort Worth$113K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.